Clal Biotechnology Industries Ltd (CBI) — Net Asset Quality Index
Clal Biotechnology Industries Ltd (CBI) has a Net Asset Quality Index of 62.5% as of June 2025. This metric measures the proportion of total assets financed by shareholders' equity — total assets of ILA52.12 Million minus total liabilities of ILA19.52 Million yields net assets of ILA32.60 Million. A higher index indicates a stronger, lower-leverage balance sheet. Check Clal Biotechnology Industries Ltd liquidity resilience to evaluate the company's liquid asset resilience ratio.
Quality Index
Net Assets
Total Assets
Total Liabilities
Clal Biotechnology Industries Ltd Net Asset Quality Index Over Time (2006–2024)
This chart shows how Clal Biotechnology Industries Ltd's Net Asset Quality Index has evolved across 19 annual periods from 2006 to 2024. As of June 2025, the index stands at 62.5%, representing net assets of ILA32.60 Million against total assets of ILA52.12 Million ILA. See Clal Biotechnology Industries Ltd current assets vs equity to evaluate short-term liquidity relative to the company's equity base.
Annual Net Asset Quality Index for Clal Biotechnology Industries Ltd (2006–2024)
The table below presents the year-by-year Net Asset Quality Index for Clal Biotechnology Industries Ltd from 2006 to 2024, covering 19 annual filings. Each row shows total assets, total liabilities, net assets, the quality index percentage, and the change in percentage points compared to the prior year. For market capitalisation and the full company profile, see CBI stock market capitalisation.
| Year | Quality Index | Net Assets (ILA) | Total Assets | Total Liabilities | Change (pp) |
|---|---|---|---|---|---|
| 2024 | 68.2% | ILA46.16 Million | ILA67.69 Million | ILA21.52 Million | ▼ -8.5 pp |
| 2023 | 76.7% | ILA121.41 Million | ILA158.39 Million | ILA36.98 Million | ▼ -2.7 pp |
| 2022 | 79.3% | ILA144.90 Million | ILA182.69 Million | ILA37.79 Million | ▲ +3.3 pp |
| 2021 | 76.1% | ILA338.37 Million | ILA444.92 Million | ILA106.55 Million | ▼ -7.6 pp |
| 2020 | 83.7% | ILA513.79 Million | ILA614.03 Million | ILA100.24 Million | ▲ +3.0 pp |
| 2019 | 80.7% | ILA497.85 Million | ILA616.97 Million | ILA119.12 Million | ▼ -4.7 pp |
| 2018 | 85.4% | ILA867.62 Million | ILA1.02 Billion | ILA148.46 Million | ▲ +7.3 pp |
| 2017 | 78.1% | ILA808.20 Million | ILA1.03 Billion | ILA226.14 Million | ▲ +10.9 pp |
| 2016 | 67.3% | ILA752.50 Million | ILA1.12 Billion | ILA366.21 Million | ▼ -4.0 pp |
| 2015 | 71.3% | ILA1.09 Billion | ILA1.53 Billion | ILA440.31 Million | ▼ -3.3 pp |
| 2014 | 74.6% | ILA1.26 Billion | ILA1.69 Billion | ILA428.44 Million | ▲ +2.7 pp |
| 2013 | 71.9% | ILA1.38 Billion | ILA1.92 Billion | ILA540.45 Million | ▼ -7.9 pp |
| 2012 | 79.8% | ILA1.40 Billion | ILA1.75 Billion | ILA354.19 Million | ▼ -8.9 pp |
| 2011 | 88.6% | ILA1.11 Billion | ILA1.25 Billion | ILA142.01 Million | ▼ -1.2 pp |
| 2010 | 89.9% | ILA1.23 Billion | ILA1.36 Billion | ILA138.20 Million | ▲ +6.3 pp |
| 2009 | 83.6% | ILA782.91 Million | ILA936.32 Million | ILA153.41 Million | ▲ +19.2 pp |
| 2008 | 64.4% | ILA274.45 Million | ILA425.92 Million | ILA151.47 Million | ▼ -9.2 pp |
| 2007 | 73.6% | ILA309.49 Million | ILA420.47 Million | ILA110.98 Million | ▼ -16.7 pp |
| 2006 | 90.3% | ILA116.28 Million | ILA128.78 Million | ILA12.50 Million | — |